DF4 Master Study (Safety and Efficacy Study)

NCT01790841 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2016-04-19

No results posted yet for this study

Summary

The purpose of the study is to proof the safety and efficacy of the new ICD sytem (Iforia/Ilesto). The devices are available with DF-1 and DF4 connection. A special focus is set on the ICD system with DF4 connection.

Conditions

Interventions

DEVICE

Iforia/Ilesto ICD/CRT-D, Linox smart DF4 lead/ Protego

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-05-31
Completion
2016-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01790841 on ClinicalTrials.gov